Department of Medicine, Genetics and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York.
Department of Medicine, Genetics and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York; Department of Physics, Brown University, Providence, Rhode Island.
Gastroenterology. 2021 Jul;161(1):211-224. doi: 10.1053/j.gastro.2021.03.017. Epub 2021 Mar 16.
Bacterial swarming, a collective movement on a surface, has rarely been associated with human pathophysiology. This study aims to define a role for bacterial swarmers in amelioration of intestinal stress.
We developed a polymicrobial plate agar assay to detect swarming and screened mice and humans with intestinal stress and inflammation. From chemically induced colitis in mice, as well as humans with inflammatory bowel disease, we developed techniques to isolate the dominant swarmers. We developed swarm-deficient but growth and swim-competent mutant bacteria as isogenic controls. We performed bacterial reinoculation studies in mice with colitis, fecal 16S, and meta-transcriptomic analyses, as well as in vitro microbial interaction studies.
We show that bacterial swarmers are highly predictive of intestinal stress in mice and humans. We isolated a novel Enterobacter swarming strain, SM3, from mouse feces. SM3 and other known commensal swarmers, in contrast to their mutant strains, abrogated intestinal inflammation in mice. Treatment of colitic mice with SM3, but not its mutants, enriched beneficial fecal anaerobes belonging to the family of Bacteroidales S24-7. We observed SM3 swarming associated pathways in the in vivo fecal meta-transcriptomes. In vitro growth of S24-7 was enriched in presence of SM3 or its mutants; however, because SM3, but not mutants, induced S24-7 in vivo, we concluded that swarming plays an essential role in disseminating SM3 in vivo.
Overall, our work identified a new but counterintuitive paradigm in which intestinal stress allows for the emergence of swarming bacteria; however, these bacteria act to heal intestinal inflammation.
细菌的群集运动(在表面的集体运动)很少与人类病理生理学相关。本研究旨在确定细菌群集运动在改善肠道应激中的作用。
我们开发了一种多微生物平板琼脂检测方法来检测群集运动,并筛选了具有肠道应激和炎症的小鼠和人类。从化学诱导的小鼠结肠炎以及炎症性肠病患者中,我们开发了分离优势群集细菌的技术。我们开发了群集缺陷但生长和游泳能力正常的突变体细菌作为同基因对照。我们在结肠炎小鼠中进行了细菌再接种研究、粪便 16S 和元转录组分析,以及体外微生物相互作用研究。
我们表明,细菌群集运动在小鼠和人类中高度预测肠道应激。我们从鼠粪便中分离出一种新型肠杆菌群集菌株 SM3。与突变株相比,SM3 和其他已知共生群集菌可减轻小鼠的肠道炎症。用 SM3 而非其突变体治疗结肠炎小鼠,可使属于拟杆菌科 S24-7 的有益粪便厌氧菌富集。我们观察到在体内粪便元转录组中存在与 SM3 群集相关的途径。在体外,S24-7 的生长在 SM3 或其突变体存在时被富集;然而,由于 SM3 而非突变体在体内诱导 S24-7,我们得出结论,群集运动在体内传播 SM3 中发挥着至关重要的作用。
总的来说,我们的工作确定了一个新的但违背直觉的范式,即在肠道应激允许群集细菌出现的情况下;然而,这些细菌可以治疗肠道炎症。